Circulating natural killer cells in Sjögren's syndrome. 1985

Y Ichikawa, and M Yoshida, and M Takaya, and M Uchiyama, and H Shimizu, and S Arimori

Reduced natural killer (NK) cell activity of peripheral blood lymphocytes (PBL) has been reported in a number of diseases including Sjögren's syndrome (SS). In this study, we used 2 monoclonal antibodies directed toward NK cells (anti-Leu-7 and anti-Leu-11) for determining NK cell activity in 29 patients with SS (9 with primary SS and 20 with secondary SS). The NK activity of PBL was simultaneously determined by the 51Cr release method using K562 as target cells. Contrary to previous reports, we did not find reduced NK activity of PBL in our patients compared with sex- and age-matched healthy controls. Although the percentage of Leu-7+ cells was significantly higher in the patients than in the controls (P less than 0.05), the absolute number of circulating Leu-7+ cells was not different between the groups. The percentage of Leu-11+ cells, however, was not significantly different between the patients and the controls, but the number of circulating Leu-11+ cells was significantly fewer in the patients than in the controls (P less than 0.05). Between the primary and secondary SS groups, no significant differences were found in NK cell activity or in the percentage of Leu-7+ or Leu-11+ cells. Furthermore, we found a significant correlation of NK activity with the percentage of Leu-11+ cells (P less than 0.05) in the controls as well as the SS patients, although a significant correlation was not identified between NK activity and the percentage of Leu-7+ cells.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007930 Leucine An essential branched-chain amino acid important for hemoglobin formation. L-Leucine,Leucine, L-Isomer,L-Isomer Leucine,Leucine, L Isomer
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012859 Sjogren's Syndrome Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis. Sicca Syndrome,Sjogren Syndrome,Sjogrens Syndrome,Syndrome, Sicca,Syndrome, Sjogren's

Related Publications

Y Ichikawa, and M Yoshida, and M Takaya, and M Uchiyama, and H Shimizu, and S Arimori
July 2003, The British journal of dermatology,
Y Ichikawa, and M Yoshida, and M Takaya, and M Uchiyama, and H Shimizu, and S Arimori
April 2022, Clinical rheumatology,
Y Ichikawa, and M Yoshida, and M Takaya, and M Uchiyama, and H Shimizu, and S Arimori
January 2004, The Journal of asthma : official journal of the Association for the Care of Asthma,
Y Ichikawa, and M Yoshida, and M Takaya, and M Uchiyama, and H Shimizu, and S Arimori
January 2000, Journal of occupational and environmental medicine,
Y Ichikawa, and M Yoshida, and M Takaya, and M Uchiyama, and H Shimizu, and S Arimori
January 2013, PloS one,
Y Ichikawa, and M Yoshida, and M Takaya, and M Uchiyama, and H Shimizu, and S Arimori
September 1998, The American journal of medicine,
Y Ichikawa, and M Yoshida, and M Takaya, and M Uchiyama, and H Shimizu, and S Arimori
April 2022, Chinese medical journal,
Y Ichikawa, and M Yoshida, and M Takaya, and M Uchiyama, and H Shimizu, and S Arimori
June 2015, Journal of translational medicine,
Y Ichikawa, and M Yoshida, and M Takaya, and M Uchiyama, and H Shimizu, and S Arimori
May 1988, Clinical and experimental immunology,
Y Ichikawa, and M Yoshida, and M Takaya, and M Uchiyama, and H Shimizu, and S Arimori
April 2001, Leukemia & lymphoma,
Copied contents to your clipboard!